Illumina Puts Up Yet Another Glowing Quarter
Insights - Illumina (ILMN) yet again posted great quarterly numbers, surpassing consensus on revenue and earnings.
Read nowInsights - Illumina (ILMN) yet again posted great quarterly numbers, surpassing consensus on revenue and earnings.
Read nowResearch - For long-term PropThink subscribers, few investments have yielded higher profits than Illumina (ILMN). Since our initiation of coverage in November 2012, shares of the San Diego-based company … Continue Reading
PremiumLong Ideas - Shares of Illumina (ILMN) have risen over 85% since our in-depth November 1, 2012 initiation of coverage, and for good reason: the company has, for … Continue Reading
Read nowLong Ideas - Since we initiated in-depth coverage of Illumina (ILMN) on November 1, 2012, shares of the gene sequencing company have soared over 66% through the close … Continue Reading
Read nowLong Ideas - On April 22, after the close of trading, Illumina (ILMN) released its Q1 2013 earnings, delivering another solid quarter in the face of perceived uncertainty. … Continue Reading
Read nowLong Ideas - The news this week that Thermo Fisher Scientific (TMO) will be coughing up $13.6B to acquire Life Technologies’ (LIFE) finally brought to earth rumors that … Continue Reading
Read nowLong Ideas - On the evening of March 14, Illumina (ILMN) announced that a federal jury found it guilty of infringing a patent held by Syntrix Biosystems relating … Continue Reading
Read now